Cases (PCa) and benign prostatic hyperplasia (BPH) controls mostly (25 out of 31 individuals: 80,6%) fall within the serum PSA diagnostic “grey zone” (4–10 ng/ml). The gene discussed is KLK3; the disease is benign prostatic hyperplasia.